AHNAK and hepatocellular carcinoma: Immunoreaction to AHNAK has mainly been observed in the cytoplasm of normal cells compared with melanoma [10] and bladder urothelial carcinoma cells [22], whereas high levels of AHNAK have been shown to predict a poor outcome in PDAC [11], HCC [17] and laryngeal carcinoma [12].